Skip to content

A Prospective Outcome Study in Patients With Moderate to Severe Traumatic Brain Injury

A Prospective Outcome Study in Patients With Moderate to Severe Traumatic Brain Injury in Bergamo Area (Italy)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03810222
Acronym
TBI-PRO
Enrollment
225
Registered
2019-01-18
Start date
2017-01-18
Completion date
2020-01-31
Last updated
2021-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Traumatic, Brain Injury Traumatic Moderate, Brain Injury Traumatic Severe

Keywords

TBI moderate, TBI severe, GOSE

Brief summary

Traumatic brain injury (TBI) is the leading cause of death, disability and cognitive impairment in young people worldwide. The majority of the traumatic deaths in developed countries results directly from lesions in the central nervous system. Furthermore, due to the persistence of disabling effects of TBI for many years, personal and public costs of supporting survivors have to be taken in consideration. Many patients rescued by ICU treatment may have been severely disabled or vegetative because of trauma. These data suggest that, despite improvement in medical and surgical treatments, other factors related to trauma itself and to patient's condition could have an impact on the final outcome. Aim of the TBI-PRO project is to collect high quality clinical and epidemiological data and to describe the outcome of moderate-to-severe TBI in a local contest (Bergamo area, Italy).

Detailed description

All patients admitted to the ICU with a diagnosis of moderate-to-severe TBI, with or without polytrauma, are recruited. Bergamo hospital is the main Trauma Centre (Level I) and the only referring neurosurgical center within a population of 1.2 million inhabitants of Bergamo area. This hospital is also a Regional Pediatric Trauma Centre.

Interventions

This is an observational study and does not include interventions. Exposure is TBI.

Sponsors

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* admission to ICU * diagnosis of moderate-to-severe TBI

Exclusion criteria

Patients who died in the first couple of hours after hospital admission are not included.

Design outcomes

Primary

MeasureTime frameDescription
Glasgow Outcome Scale - Extended (GOSE)12 Months Post-InjuryThe global functional outcome at 12 months is assessed using the Glasgow Outcome Scale-Extended (GOS-E), obtained through structured interview. The GOS-E is a well-validated, widely employed measure of disability based on information on independence, employability, and social/community participation. The baseline function prior to injury is assessed to ensure that the deficit can be attributed to the event. GOS-E is dichotomized into favorable (a score of 5 to 8, Moderate Disability is defined by a score of 5-6) and unfavorable (a score of 1 to 4, Dead is defined by a score of 1).

Secondary

MeasureTime frameDescription
6-Month Outcome6 Months Post-InjuryThe functional outcome at 6 months is assessed using the GOS-E, neuroradiological findings (MRI Brain scan or CT) obtained within a 6 month-period post-injury are also considered.
Neuropsychological evaluation12 Months Post-InjuryA neuropsychological test battery is designed to evaluate the cognitive domains commonly affected in survivors of moderate to severe TBI.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026